Literature DB >> 6359227

Experience in the management of hypertension with unilateral chronic pyelonephritis: results of nephrectomy in selected patients.

K Siamopoulos, L Sellars, S C Mishra, D M Essenhigh, V Robson, R Wilkinson.   

Abstract

We report the experience of a regional centre serving a population of 3 millions in the management of patients with hypertension and unilateral scarred kidneys between 1972 and 1981. Thirty one patients were studied, fifteen have been subjected to nephrectomy and sixteen managed conservatively. The medically and surgically treated patients differed only in that the diseased kidney was smaller, 7.7 +/- 1.9 vs 9.9 +/- 1.7 cm, (p less than 0.01), and systolic blood pressure higher, 224 +/- 34 vs 198 +/- 30 mmHg, (p = 0.05), in the surgically treated group. Following nephrectomy blood pressure was normal without drugs in four patients, control was made easier in 10 patients and only one patient, who had bilateral disease, failed to benefit. In the non-surgical group drugs could be withdrawn in only one patient and control became easier in only five. Serum creatinine did not increase following nephrectomy, but had increased significantly at the time of the most recent follow up in the medically treated patients (89 +/- 20 to 102 +/- 32 mumol 1(-1), p less than 0.05). We conclude that nephrectomy is of value in the management of some patients with unilateral chronic pyelonephritis and need not result in loss of renal function. Renal vein renin studies may be helpful in selecting patients for surgery but examination of the effect of nephrectomy in patients without differences in renal vein renin is necessary to establish this.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6359227

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  2 in total

1.  Management of unilateral chronic pyelonephritis.

Authors:  R Wilkinson
Journal:  J R Soc Med       Date:  1985-04       Impact factor: 5.344

2.  Nephrectomy in unilateral chronic pyelonephritis. A long-term follow-up study.

Authors:  B Bergman; O Norrgård
Journal:  Int Urol Nephrol       Date:  1990       Impact factor: 2.370

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.